Year Established :
1970
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
more than 1000
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages :
Cisen Pharma, which can covers from the API to FP, the whole industry chain, can meet your one-stop purchase requirement.
Patents and Copyrights :
N.A.
Business Type :
Manufacturer
R&D Capacity :
OEM
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
Central/South America,Asia,Middle East,Africa
Product Range :
Dosage form : Oral Solid Dosage; Small Volume Parenteral Injection; Large Volume Parenteral Injection; Lyophilized Powder for Injection; External Use Preparation(Ointment\eye drop\cream); API;
Therapeutic Area : CVD; Anesthesia; Antidiebates; Antineoplastic; Antihypertension; Parenteral Nutrition; Gastrointestinal; Respiratory;